MPMarcelo DE Toledo Petrilli

Marcelo DE Toledo Petrilli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marcelo DE Toledo Petrilli has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Benefício clínico e segurança do denosumabe no tumor de células gigantes do osso: revisão sistemática e meta-análise de braço único

    by Francisco Wellington Lopes Guimarães Filho, Marcelo De Toledo Petrilli, Jairo Greco Garcia, Reynaldo Jesus-Garcia Filho, Caio Falk Giannotti, Ariane Butke Brandt, Rafael Muller dos Santos

    O tumor de células gigantes do osso é uma neoplasia osteolítica localmente agressiva na qual o denosumabe se tornou uma opção sistêmica importante, porém ainda há incerteza quanto à durabilidade do controle e à segurança em esquemas do mundo real. Este estudo teve como objetivo sintetizar a efetividade e a segurança do tratamento baseado em denosumabe em pacientes com TCGO com maturidade esquelética. Realizou-se busca nas bases PubMed, EMBASE, Scopus e Cochrane Library estudos clínicos em texto completo e em língua inglesa que avaliaram denosumabe em pacientes com maturidade esquelética e tumor de células gigantes do osso até janeiro de 2026. Os desfechos primários foram benefício clínico e eventos adversos, e os desfechos secundários foram resposta por imagem, recidiva local e falha do tratamento. Uma meta-análise de braço único com modelo de efeitos aleatórios foi realizada, com estabilização de variância e ponderação pelo inverso da variância. A heterogeneidade foi quantificada pelo I², e intervalos preditivos e análises leave-one-out foram utilizados para avaliar a robustez. As análises de subgrupo foram limitadas ao desenho do estudo. Foram analisados 22 estudos, incluindo 1.170 pacientes. A taxa combinada de benefício clínico foi de 79,94% (IC 95% 74,21–85,02; I² 85,8%), e a taxa combinada de resposta por imagem foi de 72,72% (IC 95% 59,46–84,04; I² 97,2%). A recidiva local ocorreu em 24,49% dos pacientes (IC 95% 14,30–36,54; I² 96,5%) e a falha do tratamento em 10,36% (IC 95% 6,74–14,69; I² 57,0%). A taxa combinada de eventos adversos foi de 31,16% (IC 95% 6,76–63,08; I² 98,5%). A análise de subgrupo por desenho do estudo não reduziu de forma consistente a heterogeneidade, os intervalos preditivos foram amplos para a maioria dos desfechos e a meta-regressão utilizando idade média e a proporção de pacientes do sexo feminino não identificou moderadores significativos das estimativas combinadas. Observou-se que o denosumabe esteve associado a benefício clínico significativo e resposta radiológica em pacientes com maturidade esquelética e TCGO, porém, a durabilidade do controle e as estimativas de segurança variaram amplamente entre os estudos, ressaltando a necessidade de desfechos padronizados e de evidência prospectiva comparativa.

  • Open Access

    ANEURYSMAL BONE CYST: A CASE SERIES OF AN AGGRESSIVE BENIGN TUMOR

    by Caio Falk Giannotti, Nathalia Sundin Palmeira de Oliveira, Jairo Greco Garcia, Marcelo de Toledo Petrilli, Dan Carai Maia Viola, Reynaldo Jesus Garcia Filho

    Objective: The Aneurysmal Bone Cyst (ABC) is a benign yet aggressive bone tumor. This study aimed to evaluate sex, age, tumor location, tumor size, type of treatment (surgical, infiltration, embolization), and recurrence. Methods: Descriptive and quantitative statistical analyses were applied. The prevalence ratio and 95% confidence interval were calculated for the association between recurrence and sex, age, tumor size, Capanna's classification, and treatment type. Results: Twenty-three cases of ABCs were included, eleven (47.8%) females and twelve (52.2%) males. The mean age of treated patients was 11.2±1.8 years. Most cysts were located in the lower limbs (56.5%). The mean follow-up time was 42.8±14.01 months. The mean cyst diameter at the beginning of treatment was 5.58± 1.04 cm; of these, 17.4% were up to 3 cm, 43.5% from 3.1 to 6 cm, and 39.1% over 6 cm. Regarding initial treatment, 6 (26%) patients received infiltration, and in total 20 (86.9%) underwent surgery with bone grafting. The overall recurrence rate was 30.4%. No association was identified between recurrence and the variables studied (p ≥ 0.05). The epidemiological data obtained are consistent with pediatric cohorts reported in the literature. Conclusion: All evaluated methods are suitable for treating aneurysmal bone cysts. Level of Evidence IV; Case Series.


  • Open Access

    EPIDEMOLOGICAL, RADIOGRAPHIC AND PROGNOSTIC EVALUATION OF CHONDROBLASTOMA

    by Bernardo Lopes Crisostomo, Julia Pozzetti Daou, Jairo Greco Garcia, Marcelo DE Toledo Petrilli, Dan Carai Maia Viola, Reynaldo Jesus Garcia Filho

    Objective: To describe the clinical and imaging characteristics of chondroblastoma and identify possible factors related to joint complications.

  • Open Access

    DIAGNOSTIC COMPETENCE IN BONE TUMORS: INFLUENCE OF ONCO-ORTHOPEDIC TRAINING

    by Julia Pozzetti Daou, Caio Falk Giannotti, Jairo Greco Garcia, Marcelo de Toledo Petrilli, Dan Carai Maia Viola, Reynaldo Jesus Garcia Filho

    Understanding the nature of musculoskeletal tumors is crucial for appropriate management and to secure a favorable prognosis. Orthopedists’ ability to identify these pathologies early and accurately is paramount. There is a requirement to raise awareness within the orthopedic community regarding the necessity of referrals to orthopedic oncology specialists, as delays in initiating proper treatment can compromise patient prognosis. Objective: The objective was to assess the capability of non-specialist orthopedists in identifying bone lesions suggestive of tumors and thus classify them by employing a questionnaire with radiographs and comparison with specialists. We aim to gain an in-depth understanding of their diagnostic competence and provide insights into teaching the subject in orthopedic residency programs. Methods: The sample consisted of 90 participants who answered the questionnaire: 18 orthopedic oncology specialists, 58 non-specialist orthopedists, and 14 orthopedic residents. Results: Specialists achieved an average accuracy of 12.50 ± 1.07, while non-specialists scored 10.00 ± 0.60 (p<0.001). Among non-specialists, there was no statistical significance when comparing whether they underwent specialization internship during residency nor the duration of the year of such training. The period since graduation also indicated no differences. Conclusion: This study highlights the importance of referring patients with suspected tumors to specialized orthopedists. Level of Evidence V; Expert Opinion.

  • Open Access

    EPIDEMIOLOGICAL PROFILE AND EVOLUTION IN MUSCULOSKELETAL TUMORS AT THE LEVEL OF THE ELBOW

    by Vinicius DE Abreu Mazzolin, Julia Rocha Kalluf, Fiama Kuroda Ogata, Nathalia Sundin Palmeira DE Oliveira, Jairo Greco Garcia, Marcelo DE Toledo Petrilli, Marcos Korukian, Dan Carai Maia Viola

    Objective: To present the epidemiological profile of bone and soft tissue tumors that affect the elbow region treated at an oncology referral center in Brazil. Methods: Retrospective observational case series study to evaluate the results of elbow cancer undergoing clinical and/or surgical treatment with the first visit from 1990 to 2020. The dependent variables were benign bone tumor, malignant bone tumor, benign soft tissue tumor, malignant soft tissue tumor. Independent variables were sex, age; presence of symptoms (pain/increase in local volume/fracture); diagnosis; treatment and recurrence. Results: In total, 37 patients were included, 51.35% of whom were female, with a mean age at diagnosis of 33.5 years. Soft tissue neoplasms correspond to 51% of cases against 49% of bone tumors. Among the symptoms, the general prevalence of pain was 56.75%, the general increase in local volume occurred in 54.04% of the patients and the presence of fractures in 13.43%. Surgical treatment occurred in 75.67% of cases and recurrence in 16.21% of cases. Conclusion: The tumors that affect the elbow in our series correspond mostly to benign tumors, involving bone or soft tissues, with a higher occurrence in young adult patients. Level of Evidence IV, Case Series.


  • Open Access

    EPIDEMIOLOGICAL PROFILE AND EVOLUTION OF ANKLE MUSCULOSKELETAL TUMORS

    by Nathalia Sundin Palmeira DE Oliveira, Jairo Greco Garcia, Julia Rocha Kalluf, Fiama Kuroda Ogata, Barbara Mora Haring, Marcelo DE Toledo Petrilli, Marcos Korukian, Dan Carai Maia Viola

    Objective: Characterizing ankle tumors, presenting the epidemiological profile of these lesions. Methods: Retrospective observational case series study to evaluate the results of clinical and/or surgical treatments of patients with ankle tumors whose first visit occurred from 1990 to 2020. The dependent variables were: benign bone tumor, malignant bone tumor, benign soft tissue tumor, malignant soft tissue tumor, and infection. The independent variables were: sex, age; presence of symptoms (pain/local volume increase/fracture), duration of symptoms until treatment, diagnosis, treatment, and recurrence. Results: In total, 70 patients were included-58.5% were women, with a mean age at the time of diagnosis of 21.66 years. Among all cases, 76% were bone tumor, 14% were soft tissue tumor, and 10% were infection. The mean age at the time of diagnosis was 21.7 ± 2.29 years. The overall prevalence of pain was 77.1%. In total, 55.6% patients had a general local volume increase 13.4% had fractures. The mean time from symptoms to treatment was 17.4 ± 4.61 months and the mean diagnosis time was 10.13 ± 0.86 months. Of all cases, 73.44% underwent surgical treatment and 22.64% had recurrence. Conclusion: In this series, ankle tumors corresponded mainly to bone tumors. Benign tumors were the most prevalent type of tumor and the highest occurrence was among young people. Level of Evidence IV, Case Series.


  • Open Access

    JUXTACORTICAL OSTEOSARCOMA: CLINICAL EVOLUTION AND DEDIFFERENTIATION RELATED FACTORS

    by Dan Carai Maia Viola, Allan Silva Rocha, Bernardo Lopes Crisostomo, Jairo Greco Garcia, Marcelo DE Toledo Petrilli, Marcos Korukian

    Objective: Evaluate risk factors related to clinical evolution and dedifferentiation of parosteal (juxtacortical) osteosarcoma to high-grade osteosarcoma. Methods: Retrospective cohort study performed over a period of 25 years, using data from medical records of patients diagnosed with parosteal osteosarcoma. The data were submitted to statistical analysis by Fisher’s exact test and Student’s t-test. Results: Of the 326 patients treated for osteosarcoma, we identified 17 patients diagnosed with parosteal osteosarcoma. Of these, 4 (23.5%) were not actually diagnosed with parosteal osteosarcoma and 4 did not have the minimum data required for analysis, being excluded from the study. Of the 9 patients studied, we observed that 3 (33.3%) evolved with tumor dedifferentiation to high-grade osteosarcoma. Moreover, 2 (66.7%) had local recurrence and 2 (66.7%) metastases. Conclusion: Age, sex, and the tumor size were not directly related to the dedifferentiation from parosteal osteosarcoma to high-grade osteosarcoma. The most aggressive clinical evolution - presence of local recurrences and metastasis - in parosteal osteosarcoma occurred in tumors with dedifferentiation, however, we cannot associate each other as cause and effect, but as related factors. Level of Evidence IV, Case Series.


  • Open Access

    Fatores de risco relacionados a má evolução no tratamento da infecção periprótese não convencional

    by Dan Carai Maia Viola, Henrique Ribeiro Rodrigues Neto, Jairo Greco Garcia, Marcelo de Toledo Petrilli, Fabianne Altruda de Moraes Costa Carlesse, Reynaldo Jesus-Garcia Filho

    Resumo: Objetivos O objetivo do estudo é identificar os principais fatores de risco relacionados a má evolução do tratamento da infecção periprótese. Métodos Foram avaliados de forma retrospectiva os prontuários de 109 pacientes submetidos a cirurgias de endoprótese não convencional (primárias e revisões), no período de 01 de janeiro de 2007 a 31 de dezembro de 2018. Destes, 15 pacientes diagnosticadas com infecção periprótese foram elegíveis para a participação no estudo. As variáveis sexo, idade do diagnóstico, osso acometido, duração da cirurgia, contagem de leucócitos no pré-operatório, infecção do trato urinário no 1° ano pós-operatório e tempo decorrido entre a colocação da endoprótese e o diagnóstico da infecção foram relacionadas aos desfechos utilizando o Teste Exato de Fisher (variáveis bicategóricas) e o Teste Anova (variáveis tricategóricas). A média de tempo entre diagnóstico e desfecho foram comparadas pelo método de t-student. Resultados Os fatores de risco avaliados não demostraram correlação estatisticamente significante com os desfechos. Os dados demonstram haver tendência de diferença entre a média de tempo do aparecimento do processo infeccioso e o desfecho final do paciente. Devido a amostra limitada, acreditamos que estudos com coortes maiores possam comprovar essa tendência. Conclusão Identificamos que o tempo entre a cirurgia de colocação da endoprótese e o aparecimento dos sintomas de infecção tende a ter relação com o desfecho e a evolução do paciente no tratamento da infecção periprótese. Os demais fatores associados, apesar de aparentemente relacionados, também não se mostraram estatisticamente relacionados a má evolução no tratamento.